Key result
Infant cardiomyopathy is associated with high morbidity and poor prognosis, with an estimated survival and freedom from transplant of 50% at 6 years.
Population
35 patients diagnosed with cardiomyopathy within their first year of life (newborns and infants)
Design
Cohort
Follow-up
median 1.5 years (range 0-9 years)
Authors
Loading...
Highlights need for early risk stratification; leaves open etiology-specific therapeutic trials.
Cohort (n=35)
No
Infant cardiomyopathy has a highly heterogeneous etiology and carries a poor prognosis, with severe heart failure symptoms in the first month of life predicting significantly worse outcomes.
Badertscher et al. (2008) conducted a cohort in Infant cardiomyopathy (n=35). Infant cardiomyopathy is associated with high morbidity and poor prognosis, with an estimated survival and freedom from transplant of 50% at 6 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: